A Living Drug Could Be First Treatment for Stiff Person Syndrome
⏮ BeforeStiff person syndrome has no approved treatment specifically for it.
✅ NowA CAR T cell therapy is awaiting FDA approval as a possible first treatment.
In short
- Kyverna Therapeutics has a CAR T cell therapy under FDA review.
- If approved, it would be the first treatment for stiff person syndrome.
- The therapy is a living drug built from a patient's own immune cells.
Why the Good News Desk likes this one
Stiff person syndrome is a rare autoimmune disease with few approved treatments. CAR T therapy reprograms a patient's own immune cells to target the cause. The source says approval is still pending, so the path to patients is not yet confirmed.
Advertisement
From Science News
If given the green light by the FDA, a CAR T cell therapy from Kyverna Therapeutics would be the first approved treatment for stiff person syndrome.
Ask this story
Next in today's ten
Advertisement